Case Study: How A Global Pharma Company Targeted a KOL Engagement Strategy Specific to Rheumatology
This case study is useful for anyone working to anticipate market access issues and develop plans for launching new drugs in key markets.
Jim Wilkinson, PhD: Developing Staff to be the Leaders of Tomorrow
In this interview recorded at the MAPS 2023 Annual Meeting in Nashville, MAPS speaks with Jim Wilkinson, PhD, Vice President, Global & US Medical Affairs, Amgen, about how to develop Medical Affairs talent into tomorrow’s leaders.
Patient Engagement in the Early Drug Discovery Phase: The Role of Medical Affairs
In this webinar we will explore practical approaches to engaging patients in early development, introducing key resources and discussing best practices. These discussions will be tailored to meet the needs of all Medical Affairs colleagues, regardless of experience.
The Mission, Value, and Roles of Medical Affairs in MedTech
This White Paper draws on the expertise of 10 senior Medical Affairs leaders across diverse global organizations to describe the role of Medical Affairs in ensuring the MedTech industry meets the challenges of high-quality evidence, objective measures, changes in the healthcare landscape, and more.
Real-World Evidence: What Can You Say to Payers and Patient Advocates?
This presentation, part 3 of 3, provides insights into the types of communications that the FDA has indicated are or are not permissible, and the uncertainties that still remain.
Explore, Educate, Embrace: Opportunities for Medical Affairs to Impact Health Disparities & Inequities
By using the framework of Explore, Educate, Embrace we can shape our approach to Health Equity by incorporating it into our daily work.
How ChatGPT Will Disrupt Medical Affairs
ChatGPT is disrupting content creation, from term papers to journal articles to online information mills and more. This webinar gathers three thought leaders at the cutting edge of this issue to vision how ChatGPT may augment or, at times, undermine the practice of Medical Affairs in areas such as Medical Information, Omnichannel engagement and more.
Medical Affairs in Rare Disease and Gene Therapy – Why a different approach?
In today’s episode, we’ll be looking at considerations for Medical Affairs in Rare Disease and Gene Therapy
Educating Medical Professionals for that “Rare Encounter”
Streamlining the diagnostic odyssey requires educating medical professionals to recognize “rare encounters” and engage these patients with precision and compassion.